GLP-1 and GIP receptor agonists have a low intrinsic risk of causing hypoglycaemia when used alone, because their insulin-stimulating effects are glucose-dependent
These include better blood counts, reduced neurological symptoms, and overall health
Rather than supplying additional precursors, it limits NAD+ depletion by inhibiting NNMT, allowing exploration of upstream metabolic control
Clinical trials involving approximately 900 participants across six studies demonstrated excellent safety and tolerability
These benefits include: Supporting fertility, improving feelings of anxiety or depression, benefits brain health and memory, supports hair, skin and nails, and more
Another important type is methylcobalamin , which is an active form of the vitamin